Literature DB >> 8865003

Resolution of recurrent malignant ganglioglioma after treatment with cis-retinoic acid.

S E Kaba1, L A Langford, W K Yung, A P Kyritsis.   

Abstract

Ganglioglioma is an uncommon brain tumor with glial and neuronal cellular components and a somewhat benign course. We are presenting an unusual case of ganglioglioma with malignant transformation in both cellular components associated with an aggressive clinical course. An almost complete resolution of the recurrent progressing tumor was achieved after treatment with cis-retinoic acid (cRA) as a single agent. A possible differential effect of cRA on the neuronal component of the tumor is suggested.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8865003     DOI: 10.1007/bf00177443

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  19 in total

1.  Anaplastic ganglioglioma of the brain stem demonstrating active neurosecretory features of neoplastic neuronal cells.

Authors:  T Hirose; S Kannuki; K Nishida; K Matsumoto; T Sano; K Hizawa
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Inhibition of growth and development of the transplantable C-6 glioma cells inoculated in rats by retinoids and carotenoids.

Authors:  C J Wang; M Y Chou; J K Lin
Journal:  Cancer Lett       Date:  1989-11-30       Impact factor: 8.679

3.  Autologous bone marrow transplantation in children with advanced neuroblastoma.

Authors:  H Mugishima; M Iwata; I Okabe; E Sanuki; N Onuma; T Fujimoto; M Ohira; M Kaneko; Y Tsuchida; M Okuni
Journal:  Cancer       Date:  1994-08-01       Impact factor: 6.860

4.  Neuronal cell differentiation of human neuroblastoma cells by retinoic acid plus herbimycin A.

Authors:  P N Preis; H Saya; L Nádasdi; G Hochhaus; V Levin; W Sadée
Journal:  Cancer Res       Date:  1988-11-15       Impact factor: 12.701

5.  Cerebral ganglioglioma with anaplastic oligodendroglial component.

Authors:  A Allegranza; S Pileri; G Frank; R Ferracini
Journal:  Histopathology       Date:  1990-11       Impact factor: 5.087

6.  13-cis-retinoic acid (NSC 122758) in the treatment of children with metastatic neuroblastoma unresponsive to conventional chemotherapy: report from the Childrens Cancer Study Group.

Authors:  J Z Finklestein; M D Krailo; C Lenarsky; S Ladisch; G K Blair; C P Reynolds; A L Sitarz; G D Hammond
Journal:  Med Pediatr Oncol       Date:  1992

7.  Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.

Authors:  M E Huang; Y C Ye; S R Chen; J R Chai; J X Lu; L Zhoa; L J Gu; Z Y Wang
Journal:  Blood       Date:  1988-08       Impact factor: 22.113

8.  Effects of retinoic acid on expression of the transformed phenotype in C6 glioma cells.

Authors:  I Fischer; C E Nolan; T B Shea
Journal:  Life Sci       Date:  1987-07-27       Impact factor: 5.037

9.  Modulation of IGF-2 expression during growth and differentiation of human neuroblastoma cells: retinoic acid may induce IGF-2.

Authors:  G Melino; A Stephanou; M Annicchiarico-Petruzzelli; R A Knight; A Finazzi-Agró; S L Lightman
Journal:  Neurosci Lett       Date:  1993-03-19       Impact factor: 3.046

10.  Expression and down-regulation by retinoic acid of IGF binding protein-2 and -4 in medium from human neuroblastoma cells.

Authors:  S Bernardini; S Cianfarani; A Spagnoli; M Annicchiarico-Petruzzelli; G Melino; R Massoud; B Boscherini; A Finazzi-Agró; R G Rosenfeld; G Federici
Journal:  J Neuroendocrinol       Date:  1994-08       Impact factor: 3.627

View more
  4 in total

1.  Congenital ganglioglioma.

Authors:  Gengaimuthu Karthikeyan; Paiyanan Subburam; Soundian Soundian Ravishankar
Journal:  Indian J Pediatr       Date:  2002-03       Impact factor: 1.967

2.  Fenretinide activates caspases and induces apoptosis in gliomas.

Authors:  V K Puduvalli; Y Saito; R Xu; G P Kouraklis; V A Levin; A P Kyritsis
Journal:  Clin Cancer Res       Date:  1999-08       Impact factor: 12.531

Review 3.  Recognition and management of gliomas.

Authors:  S E Kaba; A P Kyritsis
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

Review 4.  Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agents.

Authors:  Athanassios P Kyritsis; Melissa L Bondy; Victor A Levin
Journal:  Nutr Cancer       Date:  2011       Impact factor: 2.900

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.